血阿皮克萨班度和血栓生成试验参数,作为对心房的剂量减少的反应
Muhan Yeo1, So-Ryoung Lee1,2, Eue-Keun Choi1,2
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
British journal of clinical pharmacology
|August 15, 2024
概括
在心房的患者中,非标注的阿皮克萨班低剂量导致药物度降低. 监测血阿皮克萨班水平可能是有益的,因为频繁的度超出范围.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 临床药房 临床药房
背景情况:
- 阿皮克萨班是用于心房动的广泛使用的抗凝剂.
- 具有剂量降低标准的患者可能会接受较低的阿皮克萨班剂量.
- 了解阿皮克萨班度及其对凝血的影响至关重要.
研究的目的:
- 在接受不同剂量的阿皮克萨班的心房动患者中,比较血阿皮克萨班度和血栓生成试验 (TGA) 参数.
- 评估当前阿皮克萨班剂量策略在具有剂量降低标准的患者中的适当性.
主要方法:
- 在374名心房患者的观察性研究中,使用了剂量降低标准.
- 患者被分为标准剂量,减少剂量和非标签低剂量组.
- 血阿皮克萨班度 (抗Xa测定) 和TGA参数在最低水平测量.
主要成果:
- 与标准剂量和减少剂量组相比,未经标签的低剂量患者的阿皮克萨班最低度明显较低.
- 很大一部分患者的度超出了预期的治疗范围.
- 较低的肌素清除预测了较高的阿皮克萨班度;标准剂量显示出最低的血栓发生率.
结论:
- 标签外的阿皮克萨班剂量不足导致药物度低于最佳.
- 血度监测可以改善阿皮克萨班治疗的管理.
- 需要进一步的研究来验证剂量标准和治疗药物监测的影响.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Clot Retraction and Fibrinolysis
5.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.0K
Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Drug Concentration Versus Time Correlation
690
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
690


